Although PDPN+ CAFs have not been studied in HGSOC, they have been associated with an immunosuppressive microenvironment and/or poor prognosis in multiple cancers, including breast, lung, esophageal, and pancreatic cancers (reviewed in [22]). This evidence concerns the gene PDPN and familial pancreatic carcinoma.